London, UK
The U.S. is the largest healthcare market in the world and one of the most challenging to navigate. For UK founders and angel investors, understanding how reimbursement actually works is often the difference between a business plan that scales and one that stalls.
Join HSBC Innovation Banking and Sie Ventures for a practical session built specifically for a UK audience, led by Dave Nelson and his team at HealthScape Advisors, a Chartis company, and Of Counsel Ty Kayam of Wilson Sonsini. Together they advise payers, providers, and healthtech companies on navigating the US regulatory and reimbursement landscape.
The session is designed to give a clear foundation, assuming limited prior exposure to the U.S. system, and to leave you with a sharper way to scope milestones and de-risk investments. You will leave with a shared understanding of the reimbursement landscape and a more concrete way to evaluate, and/or build, business plans that can scale and generate revenue.
Nancy Farestveit
nfarestveit@wsgr.com
Ty Kayam is Of Counsel in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she advises companies and investors on regulatory strategy for health technology products, with a particular focus on health AI, digital health, wearables, medical robotics, and health data infrastructure. She counsels clients throughout product development and commercialization and advises on health regulatory issues arising in financings, investments, partnerships, and strategic transactions. Her practice draws on experience at the FDA, Microsoft, and a national health information network, combining regulatory insight, technical fluency, and a systems-level understanding of how health technologies are developed, deployed, and scaled.